Idorsia Pharmaceuticals US Inc: payments to doctors
Reported under the Physician Payments Sunshine Act for Open Payments program years 2019–2025. Figures group every CMS reporting entity belonging to this corporate parent.
- Total reported
- $12M
- Providers paid
- 42,246
- Transactions
- 117,416
- Average per transaction
- $102
The average per transaction — $102 — is the number worth reading. A large total spread across hundreds of thousands of transactions is a company buying a great many modest meals at educational presentations. A large total across few transactions means consulting, speaking or royalty arrangements with a small number of physicians. The totals alone do not distinguish them.
Where the money went
| State | Total reported | Share |
|---|---|---|
| California | $2,331,172 | 19.4% |
| Florida | $2,105,353 | 17.5% |
| North Carolina | $706,035 | 5.9% |
| Georgia | $641,816 | 5.3% |
| New York | $602,936 | 5.0% |
| Texas | $581,776 | 4.8% |
| Ohio | $422,145 | 3.5% |
| Wisconsin | $354,032 | 2.9% |
| Connecticut | $344,405 | 2.9% |
| Louisiana | $324,899 | 2.7% |
| Arkansas | $286,340 | 2.4% |
| Pennsylvania | $274,208 | 2.3% |
| Virginia | $253,689 | 2.1% |
| Maryland | $194,982 | 1.6% |
| South Carolina | $194,909 | 1.6% |
| Massachusetts | $190,013 | 1.6% |
| Illinois | $180,203 | 1.5% |
| Alabama | $161,817 | 1.3% |
| Arizona | $161,788 | 1.3% |
| Indiana | $160,020 | 1.3% |
| Tennessee | $147,832 | 1.2% |
| Michigan | $134,428 | 1.1% |
| Colorado | $127,624 | 1.1% |
| Utah | $123,273 | 1.0% |
| Washington | $107,829 | 0.9% |
| New Jersey | $105,355 | 0.9% |
| Kentucky | $93,426 | 0.8% |
| Missouri | $91,749 | 0.8% |
| Mississippi | $77,088 | 0.6% |
| Nebraska | $67,504 | 0.6% |
| Nevada | $63,840 | 0.5% |
| Oklahoma | $58,714 | 0.5% |
| New Hampshire | $49,583 | 0.4% |
| Minnesota | $46,627 | 0.4% |
| Idaho | $34,772 | 0.3% |
| Delaware | $33,949 | 0.3% |
| Kansas | $29,593 | 0.2% |
| Rhode Island | $28,682 | 0.2% |
| Iowa | $27,607 | 0.2% |
| Maine | $17,138 | 0.1% |
| South Dakota | $14,356 | 0.1% |
| District of Columbia | $8,621 | 0.1% |
| West Virginia | $7,602 | 0.1% |
| New Mexico | $6,844 | 0.1% |
| Puerto Rico | $6,053 | 0.1% |
| Vermont | $5,019 | 0.0% |
| Hawaii | $4,951 | 0.0% |
| Oregon | $4,802 | 0.0% |
| Wyoming | $2,204 | 0.0% |
| Alaska | $830 | 0.0% |
| North Dakota | $744 | 0.0% |
| Montana | $595 | 0.0% |
| Guam | $305 | 0.0% |
| AE | $298 | 0.0% |
| AP | $18 | 0.0% |
Products named in Idorsia Pharmaceuticals US Inc's payments
The drugs and devices most often named as the product a payment related to. A meal at a presentation about a product counts here, so this tracks what the company promotes as much as what it sells.
- QUVIVIQ$6,730,091
- Tryvio$383,668
- APROCITENTAN$77,374
- CLAZOSENTAN$35,529
- CENERIMOD$16,190
- LUCERASTAT$12,287
- SELATOGREL$7,650
- ACT-777991$2,200
- IDOR-1117-2520$1,620
- ACT-1004-1239$1,400